Search Results
Cardiology journals retract five Matsubara studies
The American Heart Association (AHA) is retracting five studies by Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher, that it had subjected to an expression of concern last year.
Here’s the notice: Read the rest of this entry »
After three retractions, five expressions of concern, cardiologist Matsubara resigns post
Hiroaki Matsubara, a leading Japanese cardiology researcher who has had three papers retracted and another five subject to expressions of concern, has resigned from Kyoto Prefectural University, according to local media.
Mainichi Shimbun reports — according to our roughest of (Google) translations — that Kyoto Prefectural University accepted Matsubara’s resignation following an investigation. That investigation — which the university had told us about last year — revealed serious problems with 27 studies.
Five papers by prominent cardiologist Hiroaki Matsubara subject to Expression of Concern
Hiroaki Matsubara
The American Heart Association, which publishes a number of journals, has issued an Expression of Concern about five papers in three of their publications, following allegations of image manipulation. All of the papers include Hiroaki Matsubara, of Kyoto Prefectural University, as a co-author.
The notice begins:
It has come to the attention of the American Heart Association (AHA), in a public manner, that there are questions concerning a number of figures in several AHA journals’ articles…
The “public manner” was three posts last year on the Abnormal Science blog, available here, here and here, alleging that images were manipulated in the manuscripts, and that histology slides were reused.
The notice continues: Read the rest of this entry »
Lancet retracts Jikei Heart Study of valsartan following investigation
The Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.
Here’s the detailed notice for “Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study”: Read the rest of this entry »
Study of blood pressure drug valsartan retracted
Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.
As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009′s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Read the rest of this entry »
Journal retracts two papers by Japanese cardiologist under investigation
The Circulation Journal, the official organ of the Japanese Circulation Society, is retracting two papers by Hiroaki Matsubara, lead researcher on the Kyoto Heart Study, for unreliable findings. Matsubara’s institution, Kyoto Prefectural University, confirmed to us last March that it was investigating the prominent cardiologist.
The work of Matsubara came into question last year when the American Heart Association issued an expression of concern for five papers the society published in its journals. Larry Husten, at Forbes/CardioBrief, reports today that the two retracted articles were “Effects of Valsartan on Cardiovascular Morbidity and Mortality in High-Risk Hypertensive Patients With New-Onset Diabetes Mellitus: Sub-Analysis of the KYOTO HEART Study,” published in September 2012; and “Enhanced cardiovascular protective effects of valsartan in high-risk hypertensive patients with left ventricular hypertrophy: Sub-analysis of the KYOTO HEART study,” which appeared in March 2011.
The retraction notice for the most recent paper states: Read the rest of this entry »
